Your browser doesn't support javascript.
loading
Defining the Roles and Research Priorities for Psychedelic-Assisted Therapies in Patients with Serious Illness: Expert Clinicians' and Investigators' Perspectives.
Beaussant, Yvan; Sanders, Justin; Sager, Zachary; Tulsky, James A; Braun, Ilana M; Blinderman, Craig D; Bossis, Anthony P; Byock, Ira.
Afiliação
  • Beaussant Y; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Sanders J; California Institute of Integral Studies, San Francisco, California, USA.
  • Sager Z; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Tulsky JA; Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Braun IM; New England Geriatric Research, Education, and Clinical Center, Division of Geriatrics and Palliative Care, VA Boston Healthcare System, Boston, Massachusetts, USA.
  • Blinderman CD; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Bossis AP; Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Byock I; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
J Palliat Med ; 23(10): 1323-1334, 2020 10.
Article em En | MEDLINE | ID: mdl-32233936
ABSTRACT

Background:

Recent and preprohibition studies show that patients with serious illness might benefit from psychedelic-assisted therapies for a range of symptoms, physical, psychosocial, and existential.

Objective:

To explore the potential roles and research priorities of these therapies in patients with serious illness. Design, Setting, and

Participants:

Qualitative study based on semistructured interviews with 17 experts in serious illness care and/or psychedelic research from the United States and Canada. Measurements The interview guide elicited participants' perspectives on (1) the potential roles of psychedelic-assisted therapies in this setting, (2) research priorities relevant to this population, and (3) the potential for integrating psychedelic-assisted therapies into existing delivery models of serious illness care. We used thematic analysis until thematic saturation.

Results:

Domain I Participants had polar views on the therapeutic potential of psychedelic-assisted therapies, ranging from strong beliefs in their medical utility to reluctance about their use in this patient population. They shared concerns related to the risks of adverse effects, such as delirium or worsening of psychological distress. Domain II Research priorities primarily concerned patients with clinically diagnosed psychosocial distress, such as depression, anxiety, or demoralization. Participants also articulated potential roles extending beyond traditional medical diagnosis. Domain III Participants emphasized essential safety and efficacy guidelines relevant to the integration of these therapies into existing models of care.

Conclusion:

This qualitative study highlights issues and priorities for research on psychedelic-assisted therapies in patients with serious illness and proposes a conceptual framework for integrating these therapies into existing delivery models of serious illness care.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alucinógenos Tipo de estudo: Guideline / Qualitative_research Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: J Palliat Med Assunto da revista: SERVICOS DE SAUDE Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alucinógenos Tipo de estudo: Guideline / Qualitative_research Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: J Palliat Med Assunto da revista: SERVICOS DE SAUDE Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos